Urinary γ-hydroxybutyrate concentrations in 1126 female subjects

Journal of Analytical Toxicology

Volumn 34, Issue 9, 2010, Pages 555-561

  Brailsford, Alan D ^a   Cowan, David A ^a   Kicman, Andrew T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; GAMMA BUTYROLACTONE;

ACCURACY; ADULT; ARTICLE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG URINE LEVEL; DRUG USE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; MASS FRAGMENTOGRAPHY; NORMAL HUMAN; QUALITY CONTROL; RELATIVE DENSITY; SEXUAL CRIME; URINALYSIS; URINE PH; VALIDATION PROCESS;

EID: 79954603517     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.9.555     Document Type: Article

References (49)

1. A. Negrusz and R.E. Gaensslen. Analytical developments in toxicological investigation of drug-facilitated sexual assault. Anal. Bioanal. Chem. 376(8): 1192-1197 (2003).
2. M. Scott-Ham and F.C. Burton. Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. J. Clin. Forensic Med. 12(4): 175-186 (2005).
3. M. Juhascik, N.L. Le, K. Tomlinson, C. Moore, R.E. Gaensslen, and A. Negrusz. Development of an analytical approach to the specimens collected from victims of sexual assault. J. Anal. Toxicol. 28(6): 400-406 (2004).
4. M. Villain, M. Cheze, V. Dumestre, B. Ludes, and P. Kintz. Hair to document drug-facilitated crimes: four cases involving bromazepam. J. Anal. Toxicol. 28(6): 516-519 (2004).
5. B. Marc, F. Baudry, P. Vaquero, L. Zerrouki, S. Hassnaoui, and H. Douceron. Sexual assault under benzodiazepine submission in a Paris suburb. Arch. Gynecol. Obstet. 263(4): 193-197 (2000).
6. M.E. Stillwell. Drug-facilitated sexual assault involving gamma-hydroxybutyric acid. J. Forensic Sci. 47(5): 1133-1134 (2002).
7. M. Varela, S. Nogue, M. Oros, and O. Miro. Gamma hydroxybutirate use for sexual assault. Emerg. Med. J. 21(2): 255-256 (2004).
8. M. Scott-Ham and F.C. Burton. A study of blood and urine alcohol concentrations in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period. J. Clin. Forensic Med. 13(3): 107-111 (2006).
9. M. LeBeau, W. Andollo, W.L. Hearn, R. Baselt, E. Cone, B. Finkle, D. Fraser, A. Jenkins, J. Mayer, A. Negrusz, A. Poklis, H.C. Walls, L. Raymon, M. Robertson, and J. Saady. Recommendations for toxicological investigations of drug-facilitated sexual assaults. J. Forensic Sci. 44(1): 227-230 (1999).
10. L.P. Carter, H. Wu, W. Chen, M.M. Matthews, A.K. Mehta, R.J. Hernandez, J.A. Thomson, M.K. Ticku, A. Coop, W. Koek, and C.P. France. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J. Pharmacol. Exp. Ther. 313(3): 1314-1323 (2005).
11. M.E. Tunstall. Gamma-OH in anesthesia for caesarean section. Proc. R. Soc. Med. 61(8): 827-830 (1968).
12. M.S. Margulis, G.N. Andreyev, A.A. Sondore, R.L. Rosenthal, D.B. Krivulis, L.A. Andreyman, and G.I. Cimermane. Aspects of anaesthetic management of heterologous extracorporeal hepatic support in patients with acute liver failure. Resuscitation 4(2): 87-95 (1975).
13. M. Mamelak, M.B. Scharf, and M. Woods. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9(1 Pt 2): 285-289 (1986).
14. The U.S. Xyrem Multicentre Study Group, A 12-month, openlabel, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 26(1): 31-35 (2003).
15. The U.S. Xyrem Multicentre Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25(1): 42-49 (2002).
16. G. Addolorato, E. Castelli, G.F. Stefanini, G. Casella, F. Caputo, L. Marsigli, M. Bernardi, and G. Gasbarrini. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcohol. 31(4): 341-345 (1996).
17. L. Gallimberti, M. Cibin, P. Pagnin, R. Sabbion, P.P. Pani, R. Pirastu, S.D. Ferrara, and G.L. Gessa. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsycho pharmacology 9(1): 77-81 (1993).
18. L. Gallimberti, G. Canton, N. Gentile, M. Ferri, M. Cibin, S.D. Ferrara, F. Fadda, and G.L. Gessa. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2(8666): 787-789 (1989).
19. L. Gallimberti, F. Schifano, G. Forza, L. Miconi, and S.D. Ferrara. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur. Arch. Psychiatry Clin. Neurosci. 244(3): 113-114 (1994).
20. J. Takahara, S. Yunoki, W. Yakushiji, J. Yamauchi, and Y. Yamane. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J. Clin. Endocrinol. Metab. 44(5): 1014-1017 (1977).
21. J.E. Dyer. gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity. Am. J. Emerg. Med. 9(4): 321-324 (1991).
22. O. Miro, S. Nogue, G. Espinosa, J. To-Figueras, and M. Sanchez. Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate. J. Toxicol. Clin. Toxicol. 40(2): 129-135 (2002).
23. Drug-Facilitated Sexual Assault, M. LeBeau and A. Mozayani, Eds. Academic Press, London, U.K., 2001.
24. S. Abanades, M. Farre, M. Segura, S. Pichini, D. Barral, R. Pacifici, M. Pellegrini, F. Fonseca, K. Langohr, and R. de la Torre. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann. N Y Acad. Sci. 1074: 559-576 (2006).
25. R. Brenneisen, M.A. ElSohly, T.P. Murphy, J. Passarelli, S. Russmann, S.J. Salamone, and D.E. Watson. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J. Anal. Toxicol. 28(8): 625-630 (2004).
26. C.E. Crookes, M.C. Faulds, A.R. Forrest, and J.H. Galloway. A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry. J. Anal. Toxicol. 28(8): 644-649 (2004).
27. M.A. LeBeau, M.A. Montgomery, C. Morris-Kukoski, J.E. Schaff, A. Deakin, and B. Levine. A comprehensive study on the variations in urinary concentrations of endogenous gamma-hydroxybutyrate (GHB). J. Anal. Toxicol. 30(2): 98-105 (2006).
28. O.C. Snead, III, C.C. Liu, and L.J. Bearden. Studies on the relation of gamma-hydroxybutyric acid (GHB) to gamma-aminobutyric acid (GABA). Evidence that GABA is not the sole source for GHB in rat brain. Biochem. Pharmacol. 31(23): 3917-3923 (1982).
29. P. Vayer, P. Mandel, and M. Maitre. Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro. J. Neurochem. 45(3): 810-814 (1985).
30. M. Maitre, C. Andriamampandry, V. Kemmel, C. Schmidt, Y. Hode, V. Hechler, and S. Gobaille. Gamma-hydroxybutyric acid as a signaling molecule in brain. Alcohol 20(3): 277-283 (2000).
31. M. Maitre. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51(3): 337-361 (1997).
32. C. Jakobs, M. Bojasch, E. Monch, D. Rating, H. Siemes, and F. Hanefeld. Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin. Chim. Acta 111(2-3): 169-178 (1981).
33. Z. Rahbeeni, P.T. Ozand, M. Rashed, G.G. Gascon, M. al Nasser, A. al Odaib, M. Amoudi, M. Nester, S. al Garawi, and J. Brismar. 4-Hydroxybutyric aciduria. Brain Dev. 16 Suppl: 64-71 (1994).
34. P. Vayer, P. Mandel, and M. Maitre. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41(13): 1547-1557 (1987).
35. V. Hechler, P. Peter, S. Gobaille, J.J. Bourguignon, M. Schmitt, J.D. Ehrhardt, J. Mark, and M. Maitre. gamma-Hydroxybutyrate ligands possess antidopaminergic and neuroleptic-like activities. J. Pharmacol. Exp. Ther. 264(3): 1406-1414 (1993).
36. A.A. Elian. Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci. Int. 128(3): 120-122 (2002).
37. M.A. LeBeau, M.L. Miller, and B. Levine. Effect of storage temperature on endogenous GHB levels in urine. Forensic Sci. Int. 119(2): 161-167 (2001).
38. S. Kerrigan. In vitro production of gamma-hydroxybutyrate in antemortem urine samples. J. Anal. Toxicol. 26(8): 571-574 (2002).
39. M.A. LeBeau, M.A. Montgomery, C. Morris-Kukoski, J.E. Schaff, and A. Deakin. Further evidence of in vitro production of gammahydroxybutyrate (GHB) in urine samples. Forensic Sci. Int. 169(2-3): 152-156 (2007).
40. D.T. Yeatman and K. Reid. A study of urinary endogenous gammahydroxybutyrate (GHB) levels. J. Anal. Toxicol. 27(1): 40-42 (2003).
41. M.A. LeBeau, R.H. Christenson, B. Levine, W.D. Darwin, and M.A. Huestis. Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. J. Anal. Toxicol. 26(6): 340-346 (2002).
42. S.P. Elliott. Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci. Int. 133(1-2): 9-16 (2003).
43. C.J. Walker, D.A. Cowan, V.H. James, J.C. Lau, and A.T. Kicman. Doping in sport-1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone. Steroids 74(3): 329-334 (2009).
44. T. Sorahan, D. Pang, N. Esmen, and S. Sadhra. Urinary concentrations of toxic substances: an assessment of alternative approaches to adjusting for specific gravity. J. Occup. Environ. Hyg. 5(11): 721-723 (2008).
45. J.E. Haddow, G.J. Knight, G.E. Palomaki, L.M. Neveux, and B.A. Chilmonczyk. Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations. Clin. Chem. 40(4): 562-564 (1994).
46. L. Alessio, A. Berlin, A. Dell'Orto, F. Toffoletto, and I. Ghezzi. Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int. Arch. Occup. Environ. Health 55(2): 99-106 (1985).
47. Y. Suwazono, A. Akesson, T. Alfven, L. Jarup, and M. Vahter. Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers 10(2-3): 117-126 (2005).
48. P. Kintz, V. Cirimele, C. Jamey, and B. Ludes. Testing for GHB in hair by GC/MS/MS after a single exposure. Application to document sexual assault. J. Forensic Sci. 48(1): 195-200 (2003).
49. C. Saudan, M. Augsburger, P. Mangin, and M. Saugy. Carbon isotopic ratio analysis by gas chromatography/combustion/ isotope ratio mass spectrometry for the detection of gammahydroxybutyric acid (GHB) administration to humans. Rapid Commun. Mass Spectrom. 21(24): 3956-3962 (2007).